miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.

MLA

Na Ta, et al. “MiRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.” Cellular Physiology & Biochemistry (Karger AG), vol. 51, no. 2, Dec. 2018, pp. 711–28. EBSCOhost, https://doi.org/10.1159/000495328.

APA

Na Ta, Xiaoyi Huang, Kailian Zheng, Yunshuo Zhang, Yisha Gao, Lulu Deng, Bingbing Zhang, Hui Jiang, & Jianming Zheng. (2018). miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1. Cellular Physiology & Biochemistry (Karger AG), 51(2), 711–728. https://doi.org/10.1159/000495328

Chicago

Na Ta, Xiaoyi Huang, Kailian Zheng, Yunshuo Zhang, Yisha Gao, Lulu Deng, Bingbing Zhang, Hui Jiang, and Jianming Zheng. 2018. “MiRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.” Cellular Physiology & Biochemistry (Karger AG) 51 (2): 711–28. doi:10.1159/000495328.